相似文献
1
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.
Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7.
2
MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies.
Neurobiol Aging. 2013 Mar;34(3):936-42. doi: 10.1016/j.neurobiolaging.2012.06.015. Epub 2012 Jul 21.
3
MAPT haplotype diversity in multiple system atrophy.
Parkinsonism Relat Disord. 2016 Sep;30:40-5. doi: 10.1016/j.parkreldis.2016.06.010. Epub 2016 Jun 16.
4
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study.
Lancet Neurol. 2024 May;23(5):487-499. doi: 10.1016/S1474-4422(24)00083-8.
5
Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Neurobiol Aging. 2009 Sep;30(9):1477-82. doi: 10.1016/j.neurobiolaging.2007.11.019. Epub 2007 Dec 26.
6
Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.
Mov Disord. 2018 Jul;33(6):1016-1020. doi: 10.1002/mds.27385. Epub 2018 May 14.
7
Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
Mov Disord. 2019 Sep;34(9):1325-1332. doi: 10.1002/mds.27773. Epub 2019 Jun 24.
8
Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
Dement Geriatr Cogn Disord. 2016;42(5-6):255-264. doi: 10.1159/000447446. Epub 2016 Oct 6.
9
Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
JAMA Neurol. 2019 Jun 1;76(6):710-717. doi: 10.1001/jamaneurol.2019.0250.
10
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):424-9. doi: 10.1136/jnnp-2011-301413. Epub 2012 Jan 30.
引用本文的文献
1
A structural haplotype in the 17q21.31 MAPT region is associated with increased risk for chronic traumatic encephalopathy endophenotypes.
Cell Rep Med. 2025 May 20;6(5):102084. doi: 10.1016/j.xcrm.2025.102084. Epub 2025 Apr 15.
2
CNV-Finder: Streamlining Copy Number Variation Discovery.
bioRxiv. 2024 Nov 23:2024.11.22.624040. doi: 10.1101/2024.11.22.624040.
3
Dementia with Lewy Bodies: Genomics, Transcriptomics, and Its Future with Data Science.
Cells. 2024 Jan 25;13(3):223. doi: 10.3390/cells13030223.
4
The genetic basis of multiple system atrophy.
J Transl Med. 2023 Feb 10;21(1):104. doi: 10.1186/s12967-023-03905-1.
5
Retrotransposon insertions associated with risk of neurologic and psychiatric diseases.
EMBO Rep. 2023 Jan 9;24(1):e55197. doi: 10.15252/embr.202255197. Epub 2022 Nov 11.
6
Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia.
Brain. 2023 May 2;146(5):1873-1887. doi: 10.1093/brain/awac414.
7
Mitochondrial genomic variation in dementia with Lewy bodies: association with disease risk and neuropathological measures.
Acta Neuropathol Commun. 2022 Jul 14;10(1):103. doi: 10.1186/s40478-022-01399-4.
8
Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.
BMC Med. 2022 Jun 22;20(1):214. doi: 10.1186/s12916-022-02404-2.
9
Tau and MAPT genetics in tauopathies and synucleinopathies.
Parkinsonism Relat Disord. 2021 Sep;90:142-154. doi: 10.1016/j.parkreldis.2021.09.008. Epub 2021 Sep 14.
10
Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges.
Int J Mol Sci. 2021 Apr 12;22(8):3960. doi: 10.3390/ijms22083960.
本文引用的文献
1
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
Neurology. 2015 Nov 10;85(19):1680-6. doi: 10.1212/WNL.0000000000001946. Epub 2015 Sep 2.
2
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
Nat Commun. 2015 Jun 16;6:7247. doi: 10.1038/ncomms8247.
3
A novel Alzheimer disease locus located near the gene encoding tau protein.
Mol Psychiatry. 2016 Jan;21(1):108-17. doi: 10.1038/mp.2015.23. Epub 2015 Mar 17.
4
Alpha-synuclein and tau: teammates in neurodegeneration?
Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43.
5
Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.
Alzheimers Res Ther. 2014 Jul 1;6(4):39. doi: 10.1186/alzrt268. eCollection 2014.
6
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Nat Genet. 2014 Sep;46(9):989-93. doi: 10.1038/ng.3043. Epub 2014 Jul 27.
7
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
Hum Mol Genet. 2014 Dec 1;23(23):6139-46. doi: 10.1093/hmg/ddu334. Epub 2014 Jun 27.
8
Differential clinicopathologic and genetic features of late-onset amnestic dementias.
Acta Neuropathol. 2014 Sep;128(3):411-21. doi: 10.1007/s00401-014-1302-2. Epub 2014 Jun 5.
9
Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.
J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1227-31. doi: 10.1136/jnnp-2013-307228. Epub 2014 Mar 17.
10
Incidence of dementia with Lewy bodies and Parkinson disease dementia.
JAMA Neurol. 2013 Nov;70(11):1396-402. doi: 10.1001/jamaneurol.2013.3579.
Zotero 插件